geoopen
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
GEO Series GSE138717. Homo sapiens. 17 samples. Type: Expression profiling by high throughput sequencing.
ShareScore
24/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 4
- Harmonization
- 8
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 8